Omega Healthcare Investors, Inc. Q3 FY2025 earnings call

• Taylor Pickett discussed third quarter financial results, noting AFFO of $0.79 per share and FAD of $0.75 per share, with strong revenue and EBITDA growth from acquisitions and portfolio management. The dividend payout ratio was mentioned, and 2025 AFFO guidance was raised and narrowed.
• Matthew Gourmand spoke about enhancing shareholder value by expanding investment structures to align with operators, including joint ventures and minority interests, with examples like the Sabre investment. He highlighted the aim to achieve higher returns through various deal structures.
• Vikas Gupta discussed portfolio performance, new investments in Q3 2025 (including real estate acquisitions and loans), and the Sabre joint venture and equity investment. He provided details on the Sabre portfolio's coverage and occupancy.
• Bob Stephenson provided financial details, including revenue, net income, NAREIT FFO, adjusted FFO, and FAD. He also discussed the balance sheet strength, credit facility actions, and liquidity improvements.
• Megan Krull addressed regulatory and staffing-related highlights, including Medicaid cuts, staffing mandates, and regulatory changes affecting the long-term care industry.

Omega's core portfolio consists of 1,024 facilities, with 60% being skilled nursing and transitional care facilities in the U.S. and 40% U.S. senior housing and U.K. care homes. Trailing 12-month operator EBITDAR coverage for the core portfolio as of June 30, 2025, increased to 1.55x. Third quarter adjusted funds from operations (AFFO) was $0.79 per share, and funds available for distribution (FAD) was $0.75 per share. The dividend payout ratio dropped to 85% for AFFO and 89% for FAD.

• Omega raised and narrowed its 2025 adjusted FFO guidance to a range of $3.08 to $3.10 per share, up from the prior range of $3.04 to $3.07 per share. The midpoint of $3.09 per share represents 8% year-over-year AFFO growth versus 2024.
• Key assumptions in the revised guidance include no changes in revenue from operators on an accrual basis, Genesis paying full rent, derivative instruments mitigating foreign currency impact, G&A expense projections, and assumptions about investments and mortgage conversions.

• Regulatory changes, including potential Medicaid cuts and staffing mandate impacts, which could affect state budgets and operational costs.
• Competition for assets and uncertainties in executing new investment structures, which may limit the scale of certain initiatives.
• Potential challenges from state budget cuts and regulatory surveys that could impact operational margins and cash flows.

Q: Details on loan with back-end recaps, competition, and existing landlord advantage.

A: Vikas Gupta mentioned a smaller loan example with a high IRR, noting limited competition as they've proven to support operators in turnaround opportunities.

Q: Outlook on OpCo type deals, pipeline, and focus on existing tenant roster.

A: C. Pickett said Sabre-type deals are limited to unique operators, and Matthew Gourmand stated preference for known operators but openness to others with strong business models.

Q: Medicaid cuts, state profitability, and insulation from cuts.

A: Megan Krull discussed monitoring Medicaid cuts, state support, and high coverages in top states providing insulation.

Q: CMS regulatory suggestions and impact on skilled nursing facilities.

A: Megan Krull talked about rationalizing survey and rating processes to reduce unnecessary penalties on good operators, which could positively impact bottom lines.